top of page

The Black Box - Secret Drug Treatment of Rock Superstars

Disclaimer: The views and opinions expressed in the following article are those of the creator of the article and do not necessarily reflect the views or opinions of Museum of Tarot.


The Black Box Secret Drug Treatment of Rock Superstars
January 1983 Omni Magazine - The Black Box Secret Drug Treatment of Rock Superstars

"It looks like a Walkman,” explains Pete Townshend, the lead guitarist of and chief songwriter for the Who, the British rock band. "You clip this transistor-size unit onto your belt, and there’re two wires leading from it that you attach behind your ears. Then it’s a question of tuning in to the right frequency”.


The thirty-eight-year-old rock star is not describing the latest advance in record­ing technology, but a novel treatment for drug addiction - a secret drug treatment that may work by striking a melodic chord in the brain. The Walkman look-alike transmits a tiny electri­cal signal that appears to harmonize with natu­ral brain rhythms and, in the process, reduce craving and anxiety. Or at least it worked for Townshend. The little black box, he says, saved him from a nearly suicidal two-year alco­holic binge that eventu­ally drove him to heavy tranquilizers and vir­tually any other drug he could get his hands on. “The treatment works not only for boozers,’’ Town­shend emphasizes. “It's helped people give up cigarettes, heroin, barbiturates, speed, co­caine, marijuana—you name it. There is a dif­ferent frequency that works best for each kind of addiction.’’


January 1983 Omni Magazine - The Black Box Secret Drug Treatment of Rock Superstars Title Pages
The Black Box Secret Drug Treatment of Rock Superstars Title Pages

Dr. Margaret Patterson, a Scottish surgeon currently residing in southern California, is the owner and inventor of this magical device. Her black box sounds suspiciously like quack­ery. Just twiddle a few knobs and—presto—you can be cured of every imaginable vice. But the magic is real to people in the rock ’n’ roll industry, who call her a miracle worker. Apparently Town­shend is not the only celebrity who has benefited from her unusual remedy. She is credited with having reformed more than a dozen top recording stars, including ex-heroin addicts Eric Clapton and the seemingly indestructible Keith Richards, of the Rolling Stones, whose reckless abuse of drugs became as legendary as his mu­sic.


Pete Townshend on the Black Box Dr Meg Patterson Drug Treatment
Pete Townshend on the Black Box

Happily, Patterson does not fit the image of either a charlatan or a cult figure. She is in her fifties, slender of frame, with a kindly face that radiates compassion. Her pale blue eyes are set off by a magnificent mane of auburn hair, which is swept up into a graceful, oversized bun. “I hesitate to use the word cure," she says in a soft, lilting burr. "I prefer to call it a method of rapid detoxification. The electricity quickly cleanses the addict’s system of drugs, restoring the body to normal within ten days. Most patients report that their craving also subsides in the process.'


Patterson's electrical stimulator is currently pending clinical ap­proval by the Food and Drug Administration (FDA) in the United States, where she has lived since 1981. Over the last decade in Britain, however, almost 300 addicts have received NeuroElectric Therapy (NET), the technical name for her treatment. Patterson claims that all but four left drug-free at the end of the detoxification process—a remarkable 98 percent success rate. “NET should not be confused with ECT—electroconvulsive therapy for mental patients,’’ she cautions. “NET is far milder, in­ volving currents at least twenty times weaker. Patients feel only a slight tingling sensation be­ hind their ears where the electrodes are taped on.” Yet this “mild" ther­apy, she insists, will sub­due the violent physio­logical reactions that can make "going cold tur­key" intolerable for even the most strong-willed person. Though nor­mally soft-spoken, Pat­terson asserts unequiv­ocally, “I can take anyone off a drug of abuse, no matter how severe his or her addiction, with only minimal discomfort."


Of course, not all those who complete the de­toxification program re­main abstinent. Patterson emphasizes that NET is most effective when backed up by counseling, remedial training, and a supportive home environ­ment. For many individuals, however, the treatment does appear to have long lasting effects. If we are to believe the recidivism figures she cites, they are many times lower than the national average for every class of addictive drug.


A glance at Patterson's credentials provides reassurance that she is both serious and highly capable. At twenty-one, she was the youngest woman to qualify as a doctor at Scotland’s Aber­deen University. Only four years later she obtained her Fellowship at the Royal College of Surgeons, at Edinburgh University—an elite circle that few surgeons penetrate before their thirties. And just before her fortieth birthday she was presented one of her native land's highest honors by the Queen—an M.B.E., or Mem­ber of the Order of the British Empire—for her outstanding med­ical work in India.


Colleagues and patients describe the tiny Scottish surgeon as warm, confident, and virtually unflappable. “You can’t con her,' says one patient who had spent years cheating and lying to get bigger drug prescriptions. “And if you try to put one over on her. she won’t turn her back on you like other doctors."


“She’s the sort of mother you always dreamed of having," says a female addict. Still another views her as a saintly figure “with the selfless devotion of someone like Mother Theresa." Patterson’s close rapport with her patients has made some professionals question whether her dazzling record in drug re­ habilitation is really attributable to the powers of electricity. “It’s her personality" is the chief disclaimer psychiatrists have at­tached to her work. “She doesn’t control for psychological factors such as people’s expectations," says Dr. Richard B. Resnick, an associate professor at New York Medical College, who is rec­ognized as an innovator in the treatment of heroin addiction. “For example, what happens if you fasten elec­trodes to patients’ heads but don’t turn on the electricity? You just talk to them and feed them chicken soup. Will they do bet­ter, the same, or worse than the group that got current?”


Such skepticism is less common in Eng­land, where Patterson’s clinical practice was based until recently. There, a number of doctors have already begun to obtain the same beneficial effects with her electrical stimulator model.


Dr. Margaret Cameron, a psychiatrist with the National Health Service, in Somerset, England, reports that NET gives “very, very good results—better than any other treat­ment I’ve encountered.” Since May1981 Dr. Cameron has treated 40 alcoholics, 2 methadone addicts, 4 heroin addicts, and a few individuals with mixed addictions in­volving cocaine and barbiturates. In fol­low-up interviews conducted six months to a year later, 60 percent of the alcoholics were still off alcoholic beverages and none of the other patients had relapsed. A pri­vate practitioner based in New Jersey, Dr. Joseph Winston, shares Cameron’s enthusiasm for NET: “As a benign, effective technique for withdrawing people from drugs, it is virtually unmatched.”


If NET has met with resistance, it is be­ cause its mode of action strains the ex­planatory powers of modern science. Until recently orthodox medicine refused to rec­ognize that infinitesimal electrical currents may influence the behavior or function of living organisms. Currents less than 100 millivolts—or below the threshold for trig­gering a nerve impulse—were assumed to have no effect on biological processes. This dogmatic view had to be reassessed when accounts of such unsettling phenomena began appearing with increasing fre­quency in technical journals over the last decade. NET is, in fact, only one branch of a young, controversial discipline that is still struggling to achieve respectability— the science of electrical medicine.


In the early Seventies scientists began introducing very small currents via elec­trodes to different parts of the body—with dramatic results. A rat amputee was in­duced to regrow a forelimb down to the midjoint, according to one exciting—though sometimes contested—report. In human applications, the FDA has approved the use of such currents for stitching together stubborn-bone fractures. Recent experi­mental trials also indicate that trickling flows of electricity promote the healing of chronic bedsores, burns, and even peripheral­ nerve injuries. The external currents, it is theorized, stimulate rapid healing by aug­menting the body’s internal currents.


“By contrast, weak currents applied to the brain affect different physiological processes,” says Dr. Robert O. Becker, a pioneer of electrical medicine who re­cently retired from Veterans Administration Hospital, in Syracuse, New York. “But I be­lieve Dr. Patterson is producing profound alterations of the central nervous system. The psychological set that makes a person become an addict seems to disappear.”


Researchers are now starting to eluci­date NET’S scientific rationale, winning over new converts from the more conservative ranks of the medical profession. In the process, Patterson’s black box is helping to unlock the mysterious inner workings of that other black box: the human brain. The stimulus goes in, and the response comes out, but seldom are we afforded a glimpse of what happens in between. By probing NET’S effects on experimental animals, in­vestigators are shedding light on the un­derlying mechanisms that control everything from addictive behavior to our most basic drives and emotions. As Dr. Becker surmised, the stimulator does indeed cause “profound alterations of the central nerv­ous system.” Underlying consciousness is an intricate orchestral arrangement of tril­lions of brain cells, firing in concert. Like different instruments in a symphony, sub­ populations of neurons are now believed to produce frequencies within a specific range. Frequency, so to speak, is the mu­ sic of the hemispheres.


Like penicillin and X rays, NET was born of scientific serendipity. It began with an accidental discovery in the fall of 1972. At that time Patterson was head of surgery at Hong Kong’s Tung Wah Hospital, a large charity institution with a poor clientele. A neurosurgeon colleague, Dr. H. L. Wen, had just returned from the People’s Republic of China, where he had learned the tech­nique of electroacupuncture. Primarily in­terested in its usefulness in the suppres­sion of pain, he began testing it on patients with a variety of ills. Dr. Wen, however, did not know that almost 15 percent of his pa­tients were addicted to heroin or opium of extremely high purity. At that time the drugs were easily affordable at a daily cost of less than a pack of cigarettes.


“One day,” Patterson says, “an addict approached Dr. Wen, announcing that the electroacupuncture had stopped his with­drawal symptoms. ‘I felt as if I’d just had a shot of heroin,’ he said. Wen initially thought nothing of it, but a few hours later a second addict reported a similar experience, equating the electroacupuncture with a certain dosage of opium.”


Further inquiries revealed that a few al­coholics and cigarette smokers in Wen’s experimental group had also been freed from their craving. To the eye, however, the electroacupuncture produced the most dramatic response in the narcotics addicts deprived of their drugs. The characteristic runny nose, stomach cramps, aching joints, and feeling of anxiety usually disappeared after 10 to 15 minutes of stimulation by needles inserted inside the hollow of the external ear, at the acupuncturist’s lung point. At first these good effects lasted only a few hours. But with repeated treatments, patients remained symptom-free for pe­riods of longer duration.


The results of Wen’s first study with 40 opiate addicts were published in the Asian Journal of Medicine the following spring. Of this group, 39 were drug-free by the time they left the hospital, roughly two weeks after starting treatment. When Patterson returned to England in July 1973, however, she found that addicts there were far less enthusiastic about the procedure. The Chinese loved acupuncture; the British hated it. “As bizarre as it may sound,” Pat­terson explains, “Westerners—even those who mainlined drugs—often had an aver­sion to the needles.”


There was another reason not to use needles. Patterson had suspected from the outset that acupuncture was essentially an electrical phenomenon. Even the tradi­tional explanation hinted that this might be so. The ancient practice revolves around the notion that all living things possess vital energy, called chi, which circulates through the body by way of a network of channels, or “meridians.” Sickness was seen to be the result of disharmony, manifested by an obstruction in the flow of chi. which the needling was thought to remedy.


Was chi the ancients concept for what modern man now recognizes as the inter­nal currents that course through the body? Could it be that the Chinese, more than 2,500 years before the discovery of elec­tricity, had intuitively sought to alter this life force in an attempt to alleviate pain and to cure disease? Perhaps. Patterson rea­soned, the twirling of needles generates a tiny electrical voltage. Viewed in this light, the more recent practice of electroacu­puncture was simply a more intense form of the original twirling technique. If so, the electrical signal would be of crucial sig­nificance in the treatment of addictions.


Years of clinical trial and error eventually confirmed her hunch. First Patterson re­ placed needles with surface electrodes. Then she went on to compare direct cur­ rent with alternating current, while varying the voltage, shape, and other aspects of the electrical signal. Next she altered the electrode placement, finding a position just behind the ear over the mastoid bone to be more effective than the lung point. But, of all the variables explored, electrical fre­quency quickly emerged as the single most important element for success. Those ad­dicted to narcotics and sedatives pre­ferred frequencies within the 75-hertz to 300-hertz range, barbiturate addicts re­sponded to lower frequencies, and still other addicts, especially those dependent on cocaine or amphetamines, benefited most from frequencies as high as 2,000 hertz. “Musicians,” she fondly recalls, “really helped to strengthen my guesswork dur­ing those early days. They invariably found the correct therapeutic setting right away. It was as if their brains were more attuned to frequency.”


A further refinement of the therapy was prompted by still another fortuitous dis­covery: A heavy abuser fell asleep with the electrical stimulator on and awoke 30 hours later, well-rested and eager to take Patter­ son’s children ice skating. From that mo­ment onward, Patterson advocated con­tinuous current application in the initial phases of treatment. She began the search for more comfortable electrodes that could be worn during sleep and for smaller elec­trical stimulators that could be clipped onto belts, permitting mobility during the day.


By 1976 Patterson had transformed electroacupuncture into an exciting new experimental treatment mode that she christened NeuroElectric Therapy. In her first clinical study, which was reported that year in the U.N. Bulletin on Narcotics, opi­ate addicts given NET as in-patients were all found to be drug-free an average of ten months after completing treatment. In con­trast, opiate addicts who received NET only during the day as out-patients did not fare as well; 47 percent were drug-free at the time of the follow-up.


Because this preliminary investigation was limited to 23 patients, her results could not be extrapolated to a larger cross sec­tion of addicts. To provide better informa­tion about the long-term effects of NET, and also to assess its value in the treat­ment of other kinds of addictions, Patter­ son was recently awarded a research grant by the British Medical Association.


Last fall, at a Washington, D.C., sym­posium sponsored by the American Holis­tic Medical Association, Patterson presented the findings from this follow-up evaluation, which tracked the progress of patients treated between 1973 and 1980. Data were obtained from confidential questionnaires and, when possible, from personal interviews. Fifty percent re­sponded to the survey, and these re­spondents included 66 drug addicts (mostly mainline heroin or methadone users and mixed-addiction cases), 9 cigarette smokers, and 18 alcoholics. At the time of the follow-up, total abstinence was said to be achieved by 80 percent of the drug ad­dicts, 44 percent of the cigarette smokers, and 78 percent of the alcoholics who stated abstinence to be their goal. An additional 7 alcoholics whose goal on admission was controlled drinking all reported success. (As Patterson herself cautions, however, these figures probably represent too fa­vorable an outcome since patients who re­ lapsed, especially alcoholics, may have been less likely to reply to the survey.) Of those who were successfully weaned from their dependence, 68 percent said they never or only rarely experienced craving, 15 percent said they occasionally felt crav­ing, and another 17 percent said they fre­quently felt craving.


Interestingly, none of the drug addicts at the time of reporting had substituted al­cohol for their earlier addiction—a finding that contrasts sharply with the figures cited in other studies. In one national survey, for example, 60 percent of addicts who had given up narcotics became heavy drinkers or alcoholics. Equally noteworthy was the extremely low dropout rate of all addicts enrolled in the program: Only 1.6 percent did not complete detoxification.


All things considered, the success of Patterson’s patients is probably most re­ markable from the standpoint of the brief duration of the therapy, which, including counseling, rarely extends beyond 30 days. According to a large study of drug abusers admitted to a variety of government spon­sored programs, addicts treated less than three months did not fare any better than those in a no-treatment comparison group. So NET seems to achieve in a few weeks what few. if any orthodox treatments can accomplish after months or years.


Not everyone, however, is convinced by the report’s conclusions. A look at the his­tory of drug reform in the United States shows that their cynicism is not ill-founded. Consider the government s efforts to curb narcotics use. The first U.S. Public Health Service hospital for heroin addicts opened in Lexington, Kentucky, where 18,000 pa­tients were admitted between 1935 and 1952. All except some 7 percent of the alumni promptly relapsed after dismissal from the institution—a dreary record that other institutions scarcely improved upon in subsequent decades.


By the 1960s heroin addiction had spread like cancer through inner-city ghettos. To control the expanding epidemic, health professionals turned to methadone, a syn­ thetic opiate that is legally prescribed. To­ day thousands of clinics throughout the nation dispense methadone to certified addicts, and those maintained in these programs show higher rates of employ­ ment and fewer criminal offenses than be­ fore they began treatment. But metha­ done, alas, is even more addictive than heroin. As one medical authority points out, “The tragedy of methadone is that we can­ not get people off methadone.’’


For narcotics addicts who aspire to a drug-free existence, society offers two main alternatives: the highly structured and in­ sulated environments of such residential homes as Daytop Village, Phoenix House, and Odyssey House or out-patient clinics, which provide daily counseling services. As many as 30 to 40 percent of the people who enroll in these community-based pro­ grams remain abstinent a year after leav­ ing treatment. But to enter most of these programs, one must first detoxify in a hos­ pital. And here’s the hitch: 64 percent don’t make it past the acute withdrawal phase to qualify for further treatment.


“It is still not understood why simple de­ toxification is so ineffective, but the facts are clear and inescapable.-’ says Dr. Avram Goldstein, professor of pharmacology at Stanford University. “As I see it, the reason for the dismal failure ... is that the newly detoxified addict, still driven by discom­ fort, physiologic imbalance, and intense craving, cannot focus attention on the nec­essary first steps toward rehabilitation, but soon succumbs and starts using heroin.’’


Jean Cocteau, the French writer, who re­sumed smoking opium after medicine had “purged" him of the habit, put it another way: “Now that I am cured, I feel empty, poor, heartbroken, and ill."


In sharp contrast, NET patients are said to emerge from treatment feeling healthy, energetic, even cheerful. Dr. Joseph Win­ ston, the American physician who collab­ orated with Patterson in the treatment of Keith Richards, recalls that the musician “came to us terribly ill. He was literally green. But he slept eighteen hours the first day, and ten days later he was playing tennis, and the group said he had not looked so good in years."


If Patterson’s findings seem at total var­iance with the bulk of the clinical literature, the firsthand accounts of NET patients may help explain why.


Stuart Harris started shooting heroin as a sixteen-year-old cadet in the Royal Navy. By the time he underwent NET in the spring of 1981, he had been addicted to heroin 15 years, and for 11 of those years he had also injected methadone intravenously. “I had the sweats very badly," he says of his experience on NET. “You’re emitting all this bad grunge from your body, and you feel like you’re speeding [on amphetamines]. But there’s no withdrawal at all. That much I’ll say for it. I mean when they told me about it. I just took it with a pinch of salt— another treatment they've fobbed off on the poor junkies. But, believe me. if I was get­ ting any pain as I used to have with with­ drawals. I wouldn't have stayed there, ’cause I was a voluntary patient. When I discharged myself from hospital, I didn't go searching out for drugs as I would nor­ mally have done in the past, say, after methadone reduction or narcosis (that's when they sedate you up to your eyeballs on sleeping pills). After completing all the other methods. I felt so uptight all the time. The first thing I wanted to do was have a massive great fix. But. after NET all you really want to do is sleep. Everything is so easygoing. I can’t say that it [heroin] doesn't drift into my mind. Like the other day. I fan­ cied a fix. But it passed over in a few min­ utes. Before, if I’d felt the slightest urge for a fix. off I’d go to London. Something has changed. You feel calmer. You can accept the ups and downs."


A man in his thirties, who requested an­ onymity, had injected heroin for eight years, combining this dosage with prescribed methadone during the last five years of the period. He received NET in 1974. “The treatment was rough." he says. “I felt as if I had a mild case of the flu, combined with short periods of feeling spaced out—even a bit euphoric. My anxiety and craving subsided right from the beginning, but a few weeks later my craving for heroin went back up again. I wanted to go out and score. And, as a matter of fact, I did. But it was different. It wasn’t satisfying. It didn’t make me feel that great. I know this treatment changed my head, because I never thought about heroin again after that. You see. I had gotten off heroin for as much as a month, even two months, at a stretch. But the whole of that time I would be thinking of heroin and nothing else."


A twenty-eight-year-old man, who also requested anonymity, combined a high level of alcohol and marijuana consumption with a cocaine habit of two to six grams each week for more than seven years. (The co­caine alone usually cost him more than $1,000 a month.) He agreed to speak to Omni immediately after completing NET treatment in the summer of 1982. “Until this therapy,’’ he says, “I couldn’t go three days without feeling an enormous craving for drugs. Cocaine and, to a lesser degree, alcohol would always be on my mind. But from the moment the electrodes were put on my head, my craving immediately di­ minished. When I had passed the three- day mark, I felt no craving at all, and I still don’t. Drugs never enter my mind. Now that I remember what it’s like to feel good—to be clearheaded after all these years—I’m certain that I won’t go back on drugs.’’


Rachel Waite, a heavy smoker for five years, was treated for her cigarette addic­ tion in June 1981. “For the first three days on NET,’’ she recalls, “I still had the urge to smoke, and I probably would have lit up had a cigarette been handy. However, by the end of the treatment I definitely did not want one. When I took an experimental puff, it was a different sensation altogether. It tasted foul, and there was no hit whatso­ ever. It was as if I was drawing on hot air.’’


Surprisingly, many patients who go on to build drug-free lives do not receive any formal counseling beyond that provided during the brief detoxification program. Yet NET, by itself, cannot remove the root causes of addiction, nor can it replace years of maladaptation with healthy skills for coping with life’s stresses and disappoint­ ments. Why then do so many patients ex­ perience such a metamorphosis?


The treatment, Patterson believes, sim­ ply sets the stage for further growth. “Be­ cause they feel so good,’’ she says, “they are better able to face the sort of problems that drove them to addiction in the first place. You see, most people who come off drugs without NET enter a phase of pro­ longed dysphoria: They suffer from fearful depression and pessimism. They can’t eat. They can’t sleep. They have no energy. This can last for six months in the case of her­ oin, and even longer in cases of metha­ done and barbiturate addiction. But NET restores physiological normality within ten days, which enormously reduces the amount of time needed for readjustment.’’


If anything, Patterson thinks that eu­phoria—not dysphoria—is to blame when rehabilitation fails. The newly detoxified addict is optimistic to the point of being overconfident. “In their elated state,’’ Pat­terson says, “they think it will be easy to stay off drugs and then end up stumbling, because they don’t make enough of an at­ tempt to change their ways.’’


As if obeying Newtonian mechanics, the black box appears to counter one mood shift with an equal swing in the opposite direction, until the emotional pendulum fi­nally comes to rest. Is the black box, in reality, an electronic substitute for a chem­ical high? How can a physical treatment cause such a swing toward euphoria?


As fate would have it, a scientist who had taught Patterson years earlier, Dr. Hans Kosterlitz, would once again serve as her mentor by illuminating the mainspring of euphoria in the brain. While working with Dr. John Hughes at the University of Ab­ erdeen in 1975, Dr. Kosterlitz identified an endorphin, a natural brain chemical, with a molecular structure very similar to the opiates. For this outstanding discovery, the investigators later received the prestigious Lasker Award, revered as America’s equivalent of the Nobel Prize in medicine. Almost overnight their finding triggered an explosion in the understanding of the bio­ chemical basis of behavior, opening a new vista on the controlling factors behind ad­ diction. Opium, heroin, morphine, and other related drugs owe their potency to what Avram Goldstein calls “one of nature’s most bizarre coincidences’’—their uncanny re­ semblance to the endorphins.


Over the succeeding years researchers uncovered evidence of myriad other brain hormones that mimic psychoactive drugs, from Valium and angel dust to hallucino­ gens. Almost every mind-altering sub­ stance. it is now assumed, has an ana­ logue in the brain. And the precise mixture of neurojuices in this biochemical cocktail can mean the difference between tripping, speeding, crashing, or seeing the world through sober eyes.


These insights immediately suggested how the addict becomes trapped in a nightmarish cycle of dependency. In the initial phases of narcotic use, for example, the individual is assumed to have normal levels of endorphins in the brain. Injecting heroin causes a sudden and drastic ele­vation of opiates, which is subjectively in­ terpreted as ecstasy. If, through repeated use, the brain is regularly flooded with opi­ates, it redresses the imbalance by cut­ ting back on the production of its internal supply. Hence, the well-known condition of tolerance develops. The addict steps up his dosage, and the brain further compen­sates by calling a massive shutdown of production. Eventually, according to the­ ory, the addict is shooting up solely for the purpose of “feeling normal.” Should the drug supply be cut off at this stage, the opiate shortage cannot be instantly rem­edied. Drought ensues, unleashing with­drawal symptoms.


If an exogenous drug depletes the brain of its natural counterpart, it seemed logical that NET might quite literally juice up the system, rapidly replenishing the scarce neurochemical. Might certain frequencies of current catalyze the release of different brain hormones? Patterson wondered.


To find out, she conducted animal ex­periments in collaboration with biochemist Dr. Ifor Capel at the Marie Curie Cancer Memorial Foundation Research Depart­ment, in Surrey, England. Simply by mon­itoring the blood of NET-treated rats, the investigators discovered low-frequency currents can indeed cause as much as a threefold elevation of endorphin levels.


In another experiment the researchers examined NET’S effects on rats rendered unconscious by massive doses of barbit­urates. Once asleep, all the animals had electrodes clipped on to their ears, but only half the group actually received electrical current. The result: At one particular fre­ quency—ten hertz—the experimental group rapidly regained consciousness, sleeping on average 40 percent less than the rats that received no electricity.


Why is the detoxification process has­ tened? One clue surfaced when the rats' brain tissue was analyzed: It was learned that the ten-hertz signal speeds up the production and turnover rate of serotonin (a neurotransmitter that acts as a stimulant to the central nervous system).


Similar experiments have now been re­ peated on rats made unconscious by in­ jecting them with alcohol or ketamine (a cousin of angel dust). In almost every in­ stance the frequencies that reduced sleeping time had earlier been proved therapeutic in the detoxification of human addicts. “Virtually every single parameter of current that I had stumbled upon during my clinical work was corroborated by the rat studies,” Patterson declares, with barely concealed excitement.


How a weak electrical current can open the floodgates of the mind is still a matter of conjecture, but the implications are ob­vious. Like a citizen's-band transmitter that infiltrates television frequencies, the black box must broadcast through brain fre­quency channels. And just as a TV re­ceiver can pick up CB transmissions from a passing truck, the brain undoubtedly re­sponds to the foreign-generated signal as if it originated from within its own commu­nication network.


“As far as we can tell,' says Dr. Capel, a rugged Welshman with a melodic voice, “each brain center generates impulses at a specific frequency based on the pre­ dominant neurotransmitters it secretes. In other words, the brain's internal commu­ nication system—its language, if you like— is based on frequency.''


Unfortunately, neuroscientists are not yet fluent in this new tongue. "NET is still a very blunt tool." Capel acknowledges. “Presumably, when we send in waves of electrical energy at. say. ten hertz, certain cells in the lower brain stem will respond, because they normally fire within that fre­ quency range. As a result, particular mood­ altering chemicals associated with that re­ gion will be released. That's what we hope is happening. In reality, however, much of the signal may be lost before it actually reaches the target cells. We just don't know. But if we can fine-tune the signal. I am con­ fident our results will steadily improve.


At her small, two-bedroom home in Co­ rona del Mar, Patterson has begun testing a new, improved model of the stimulator. Her goal—and the major impetus behind her decision to come to the United States— is to obtain funding for the establishment of a center where human and animal re­ search can proceed in tandem. Until FDA clearance is given, however, she cannot begin treating addicts on a routine basis.


Will NET open a new route to salvation for the millions of Americans who each year flock to Alcoholics Anonymous. Smoke Enders, and methadone maintenance clin­ ics? Clearly the final verdict is contingent upon replication of controlled studies. But if a feeble electrical current can truly curb the mind’s excesses—from uncontrollable lusts to extremes of mood—its impact is sure to be far-reaching.


“Addicts may represent only a tiny frac­tion of the people who will eventually be helped by NET." Capel predicts. “In all likelihood it will find an enormous range of uses, especially in the area of pain con­trol.” In one preliminary trial, terminal pa­tients suffering from chronic pain found NET just as effective as their daily dose of mor­phine. “By stimulating the brain’s own painkillers, we didn’t have to administer drugs.” Capel marvels.

Early data also indicate that NET may prove highly promising in the treatment of mental disorders. The frequencies that in­ duce euphoria and reduce tension, ac­ cording to Dr. Cameron, of Britain’s Na­tional Health Service, “seem to work wonders for patients suffering from severe depression and acute anxiety." Though it is far too soon to draw any conclusions. She notes that “a few of the half-dozen chronic depressives we’ve treated have found themselves jobs after years of un­ employment."


As for Patterson, she hopes eventually to broaden her practice to include behav­ ioral addictions, from overeating and com­ pulsive gambling to video-game fanati­ cism. Absurdity aside, these wider applications follow a certain logic. “Her ideas make perfect sense if one accepts the idea that behavioral addictions have a chemical basis," says Dr. William Regel- son, at the Medical College of Virginia. “It is very likely, for example, that all activities vital to survival—from sex to physical ex­ ercise—are physiologically addictive. It is now thought that the phenomenon called jogger’s high is actually endorphin-me­ diated. In all probability, eating also re­ leases some kind of pleasurable molecule. After all, why do we crave food? Low blood- sugar levels don’t explain why. The truth is that we feel abnormal when we haven’t eat­ en in a while. Some chemical in our brain has become depleted. We become rest­ less and agitated, and, after extreme dep­ rivation, we suffer withdrawal symptoms commonly known as hunger pangs. The only way to relieve our discomfort is to get more food. It’s a fix—plain and simple."


If basic drives are addictive, then drugs are an ingenious means of shortcutting the elaborate scheme nature devised to en­sure that we maintain health and repro­ duce ourselves. Merely by popping a pill, we can top off our neurochemical reser­voirs with no sweat expended. Instant or­gasm without any foreplay. A cheap thrill.


But can’t the same be said of NET? “Is it not, after all, an electronic fix?" asks Re- gelson, who fears the black box may be­ come addictive in its own right. Patterson has kept her eyes open to any signs that her patients are becoming physically de­ pendent on the equipment. But she rules out the possibility that there will ever be a black market in black boxes, because in­ dividual models can cost upward of $1,000—a hefty sum to cough up for purely recreational use. Besides, she has not en­ countered a single instance of electronic addiction in her ten years of practice. The explanation, she believes, “is that drugs— for the very reason that they are foreign— upset the brain’s chemistry. NET, on the other hand, simply coaxes the brain to re­ store its own chemical balance. The body heals itself."


The intuitive feelings of her patients sup­ port this view. As reformed heroin addict Stuart Harris says, “At first I thought it would be fun to wire up the human race, so we could all go whizzing about. But after the initial buzz, you feel, well, normal. Frankly, all NET does is help you face reality."


Patterson concurs: “All we can do is give people a chance. We can get them off whatever drug they’re hooked to, but it’s up to them to fill the void. They’ve got to find a constructive substitute for the drugs that have dominated their lives."

bottom of page